S585 Disparities in Colorectal Cancer Screening Trends Among Patients With and Without Disabilities

Introduction: Colorectal cancer (CRC) screening is a crucial preventive measure, yet disparities persist among disabled populations. This study evaluates trends in CRC screening incidence, prevalence, and incidence rates between disabled and non-disabled cohorts from 2021 to 2024. Methods: We conducted a retrospective analysis using TriNetX data for patients aged 45–75. We identified 2 cohorts: disabled (n = 722,574; defined using ICD-10 codes) and non-disabled (n = 19,317,514). We measured CRC screening using CPT codes for colonoscopy, sigmoidoscopy, and fecal occult blood tests. We compared trends in incidence proportions, prevalence, and incidence rates annually. Results: CRC screening incidence proportions increased in both cohorts until 2023 but declined in 2024. The disabled cohort experienced a sharper drop (0.0145 to 0.0110) compared to the non-disabled cohort (0.0103 to 0.0095). Prevalence steadily increased across the study period, with higher rates in the disabled cohort (0.1220 in 2024 vs 0.0776 in the non-disabled cohort). Incidence rates remained higher in the disabled cohort across all years, with a slight but persistent difference compared to the non-disabled cohort. Conclusion: The steady increase in CRC screening prevalence highlights its cumulative nature; however, the 2024 decline in incidence proportion, particularly among disabled patients, suggests barriers to healthcare access, saturation among previously screened individuals, or incomplete data collection. Logistical challenges, limited mobility, and systemic inequities within healthcare systems may further contribute to these disparities, highlighting the need for tailored public health interventions that address the unique barriers faced by disabled populations. While overall CRC screening prevalence continues to rise, the decline in new screenings in 2024, particularly among disabled populations, emphasizes the importance of improving outreach, expanding equitable healthcare access, and implementing disability-focused policies within CRC screening programs to address disparities and promote equity in CRC prevention.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001129800.45364.b3
Primary Topic
Diverticular Disease and Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S585 Disparities in Colorectal Cancer Screening Trends Among Patients With and Without Disabilities

Hebah Jaber, Omar Arman, Jad Bou-Abdallah, Mazen Zamzam et al.
The American Journal of Gastroenterology
Diverticular Disease and Complications
article

S585 Disparities in Colorectal Cancer Screening Trends Among Patients With and Without Disabilities

Hebah Jaber, Omar Arman, Jad Bou-Abdallah, Mazen Zamzam, Amer Arman, Omar Daas, Mohammed Damdoum, Khaled Rafeh
article en

Abstract

Introduction: Colorectal cancer (CRC) screening is a crucial preventive measure, yet disparities persist among disabled populations. This study evaluates trends in CRC screening incidence, prevalence, and incidence rates between disabled and non-disabled cohorts from 2021 to 2024. Methods: We conducted a retrospective analysis using TriNetX data for patients aged 45–75. We identified 2 cohorts: disabled (n = 722,574; defined using ICD-10 codes) and non-disabled (n = 19,317,514). We measured CRC screening using CPT codes for colonoscopy, sigmoidoscopy, and fecal occult blood tests. We compared trends in incidence proportions, prevalence, and incidence rates annually. Results: CRC screening incidence proportions increased in both cohorts until 2023 but declined in 2024. The disabled cohort experienced a sharper drop (0.0145 to 0.0110) compared to the non-disabled cohort (0.0103 to 0.0095). Prevalence steadily increased across the study period, with higher rates in the disabled cohort (0.1220 in 2024 vs 0.0776 in the non-disabled cohort). Incidence rates remained higher in the disabled cohort across all years, with a slight but persistent difference compared to the non-disabled cohort. Conclusion: The steady increase in CRC screening prevalence highlights its cumulative nature; however, the 2024 decline in incidence proportion, particularly among disabled patients, suggests barriers to healthcare access, saturation among previously screened individuals, or incomplete data collection. Logistical challenges, limited mobility, and systemic inequities within healthcare systems may further contribute to these disparities, highlighting the need for tailored public health interventions that address the unique barriers faced by disabled populations. While overall CRC screening prevalence continues to rise, the decline in new screenings in 2024, particularly among disabled populations, emphasizes the importance of improving outreach, expanding equitable healthcare access, and implementing disability-focused policies within CRC screening programs to address disparities and promote equity in CRC prevention.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 52%
Diverticular Disease and Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.